P/E - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

P/E
Price to Earnings

-5.1
Current
12.9
Median
21.6
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-5.1
=
Market Cap
84.8m USD
/
Net Income
-62m ILS
All Countries
Close
Earnings Growth
IL
I
InterCure Ltd
NASDAQ:INCR
Average P/E: 37.7
Negative Multiple: -5.1
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
117.2
425%
DK
Novo Nordisk A/S
CSE:NOVO B
44.1
90%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
10.4
-22%
US
Merck & Co Inc
NYSE:MRK
21.7
7 419%
CH
Roche Holding AG
SIX:ROG
18.6
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
38.1
175%
CH
Novartis AG
SIX:NOVN
14
20%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -64.8
712%

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-685.4
2-Years Forward
P/E
8
3-Years Forward
P/E
N/A

See Also

Discover More